Upgrade to SI Premium - Free Trial

Axsome Therapeutics (AXSM)

206.68 -1.67 (0.80%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/9/26)

Latest Headlines

Axsome Therapeutics to Participate in Upcoming Investor Conferences September 2, 2026 7:00 AM - StreetInsider Axsome begins Phase 3 trial of AXS-05 for smoking cessation August 31, 2026 7:00 AM - StreetInsider Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation August 31, 2026 7:00 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Axsome Therapeutics (AXSM) August 24, 2026 6:45 AM - StreetInsider Axsome Therapeutics (AXSM) PT Raised to $316 at Mizuho August 12, 2026 6:36 AM - StreetInsider Axsome Therapeutics (AXSM) PT Raised to $251 at Morgan Stanley August 11, 2026 9:08 AM - StreetInsider Axsome Therapeutics (AXSM) PT Lowered to $279 at RBC Capital August 11, 2026 7:57 AM - StreetInsider Axsome Therapeutics (AXSM) PT Raised to $268 at Needham August 11, 2026 7:10 AM - StreetInsider Axsome Therapeutics (AXSM) PT Raised to $256 at Wells Fargo August 11, 2026 6:54 AM - StreetInsider Axsome Therapeutics (AXSM) PT Raised to $275 at Guggenheim August 11, 2026 6:45 AM - StreetInsider Form 10-Q Axsome Therapeutics, For: Jun 30 August 10, 2026 4:08 PM - SEC Filing Axsome Therapeutics (AXSM) Misses Q2 EPS by 14c August 10, 2026 7:39 AM - StreetInsider Form 8-K Axsome Therapeutics, For: Aug 10 August 10, 2026 7:06 AM - SEC Filing Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update August 10, 2026 7:00 AM - StreetInsider Form 4 Axsome Therapeutics, For: Aug 05 Filed by: TABUTEAU HERRIOT August 7, 2026 7:00 PM - SEC Filing Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT August 6, 2026 5:09 PM - SEC Filing Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT August 5, 2026 6:04 PM - SEC Filing Axsome Therapeutics (AXSM) PT Lowered to $306 at Mizuho July 31, 2026 6:53 AM - StreetInsider Form SCHEDULE 13G/A Axsome Therapeutics, Filed by: BlackRock, Inc. July 27, 2026 4:26 PM - SEC Filing BMO Capital Starts Axsome Therapeutics (AXSM) at Outperform July 20, 2026 4:13 PM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Axsome Therapeutics (AXSM) July 16, 2026 6:47 AM - StreetInsider Form 8-K Axsome Therapeutics, For: Jul 15 July 15, 2026 7:05 AM - SEC Filing FDA accepts Axsome drug application for cataplexy treatment July 15, 2026 7:00 AM - StreetInsider Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-12 for the Treatment of Cataplexy in Narcolepsy July 15, 2026 7:00 AM - StreetInsider Piper Sandler Reiterates Overweight Rating on Axsome Therapeutics (AXSM) July 14, 2026 7:55 AM - StreetInsider Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10 July 14, 2026 7:00 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Axsome Therapeutics (AXSM) July 8, 2026 6:40 AM - StreetInsider Axsome Therapeutics (AXSM) PT Raised to $304 at RBC Capital July 7, 2026 7:59 AM - StreetInsider Axsome starts Phase 3 trial of solriamfetol in children with ADHD July 7, 2026 7:00 AM - StreetInsider Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD) July 7, 2026 7:00 AM - StreetInsider Form 4 Axsome Therapeutics, For: Jul 01 Filed by: TABUTEAU HERRIOT July 1, 2026 7:30 PM - SEC Filing Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT July 1, 2026 5:35 PM - SEC Filing Axsome starts Phase 3 trial of solriamfetol for adolescent ADHD June 26, 2026 7:00 AM - StreetInsider Axsome Therapeutics Initiates FOCUS-3 Phase 3 Trial of Solriamfetol in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) June 26, 2026 7:00 AM - StreetInsider Axsome Therapeutics Highlights the Importance of Brain Health During Alzheimer's & Brain Awareness Month June 18, 2026 7:00 AM - Globe NewsWire Axsome Therapeutics Highlights the Importance of Brain Health During Alzheimer's & Brain Awareness Month June 18, 2026 7:00 AM - StreetInsider Axsome Therapeutics (AXSM) PT Raised to $300 at TD Cowen; 'Under-followed Pipeline Is Upside' June 17, 2026 8:25 AM - StreetInsider Axsome Therapeutics presents sleep disorder data at SLEEP 2026 conference June 15, 2026 7:02 AM - StreetInsider Axsome Therapeutics Presents New Data Highlighting its Innovative Sleep Medicine Portfolio at SLEEP 2026 June 15, 2026 7:00 AM - StreetInsider Form 4 Axsome Therapeutics, For: Jun 10 Filed by: JEFFS ROGER June 11, 2026 8:34 PM - SEC Filing Form 144 Axsome Therapeutics, Filed by: JEFFS ROGER June 11, 2026 5:10 PM - SEC Filing Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies June 11, 2026 5:34 AM - StreetInsider Form 4 Axsome Therapeutics, For: Jun 08 Filed by: JEFFS ROGER June 10, 2026 9:50 PM - SEC Filing Form 4 Axsome Therapeutics, For: Jun 08 Filed by: Saad Mark E June 10, 2026 9:50 PM - SEC Filing Form 4 Axsome Therapeutics, For: Jun 08 Filed by: Mahony Susan June 10, 2026 9:49 PM - SEC Filing Form 4 Axsome Therapeutics, For: Jun 08 Filed by: Coleman Mark June 10, 2026 9:49 PM - SEC Filing Form 144 Axsome Therapeutics, Filed by: Mahony Susan June 10, 2026 4:17 PM - SEC Filing Form 144 Axsome Therapeutics, Filed by: JEFFS ROGER June 10, 2026 4:16 PM - SEC Filing Form 144 Axsome Therapeutics, Filed by: Coleman Mark June 10, 2026 4:16 PM - SEC Filing Form 144 Axsome Therapeutics, Filed by: TABUTEAU HERRIOT June 9, 2026 6:01 PM - SEC Filing Form 8-K Axsome Therapeutics, For: Jun 05 June 9, 2026 5:21 PM - SEC Filing Form 8-K Axsome Therapeutics, For: Jun 05 June 9, 2026 5:20 PM - SEC Filing Form 4 Axsome Therapeutics, For: Jun 05 Filed by: Coleman Mark June 9, 2026 5:19 PM - SEC Filing Form 4 Axsome Therapeutics, For: Jun 05 Filed by: Mahony Susan June 9, 2026 5:18 PM - SEC Filing Form 4 Axsome Therapeutics, For: Jun 09 Filed by: TABUTEAU HERRIOT June 9, 2026 5:17 PM - SEC Filing Form 4 Axsome Therapeutics, For: Jun 09 Filed by: Pizzie Nick June 9, 2026 5:17 PM - SEC Filing Form 4 Axsome Therapeutics, For: Jun 05 Filed by: Saad Mark E June 9, 2026 5:16 PM - SEC Filing Form 4 Axsome Therapeutics, For: Jun 05 Filed by: JEFFS ROGER June 9, 2026 5:16 PM - SEC Filing Form 144 Axsome Therapeutics, Filed by: Pizzie Nick June 9, 2026 4:09 PM - SEC Filing Form 144 Axsome Therapeutics, Filed by: Mahony Susan June 9, 2026 4:07 PM - SEC Filing Full Article List